Skip to main content
Rachel Sanborn, MD, Oncology, Portland, OR, Providence Portland Medical Center

RachelElizabethSanbornMD

Oncology • Portland, OR

Full Member: Medical Director, Thoracic Oncology Program; Medical Director, Phase I Clinical Trials Program, Earle A. Chiles Research Institute, Providence Cancer Institute | Medical Oncology, Providence Portland Medical Center

Join to view full profile

Dr. Sanborn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sanborn's full profile

Already have an account?

Summary

  • Dr. Sanborn is Medical Director of the Thoracic Oncology Program at Providence Cancer Institute, and Medical Director of the Phase I Clinical Trials Program at Earle A. Chiles Research Institute, a division of Providence. She is a Full Member of the Earle A. Chiles Research Institute at Providence Cancer Institute. She is board-certified in medical oncology and internal medicine, and serves as a member of the Institutional Review Board of Providence Portland Medical Center.

    Dr. Sanborn completed her medical degree and hematology and medical oncology fellowship at Oregon Health & Science University. She attended the University of Illinois at Chicago for her residency in internal medicine.

    Dr. Sanborn is a member of several professional organizations, including the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the American Lung Association Medical Advisory Workgroup, the Southwest Oncology Group Thoracic Working Group, and the Hoosier Cancer Research Network Thoracic Clinical Trial Working Group.

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1999 - 2002
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 1999
  • Cornell College
    Cornell CollegeBA, Biology, 1995

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2005 - 2025
  • IL State Medical License
    IL State Medical License 1999 - 2002
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Targeted Onocology Cased-Based Peer Perspectives on Targeted Therapy and IO for Lung Cancer 
    Tacoma, WA (Virtual Meeting) - 8/2020
  • Case-Based Peer Perspectives in EGFR-Mutated NSCLC and in Small Cell Lung Cancer 
    Tacoma, WA (Virtual Meeting) - 6/2020
  • Maximizing the Benefits of Targeted Therapies 
    Chicago, IL (ASCO Virtual Meeting) - 5/2020
  • Join now to see all

Press Mentions

  • “All Patients Should Have Their Tumor Sequenced at Least Once”
    “All Patients Should Have Their Tumor Sequenced at Least Once”June 13th, 2022
  • TKI plus SBRT Tops TKI Alone for Oligometastatic EGFRm NSCLC
    TKI plus SBRT Tops TKI Alone for Oligometastatic EGFRm NSCLCJune 8th, 2020
  • Heat Biologics Announces First Patient Dosed in the First Phase 1 Trial of HS-130
    Heat Biologics Announces First Patient Dosed in the First Phase 1 Trial of HS-130December 16th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. Rachel Sanborn, Dr. Rachel Sanborn, MD, Dr. R Sanborn, Dr. Rachel Elizabeth Sanborn